In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose of neffy in the same nostril with a new nasal spray starting 5 minutes after the ...

School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy® (epinephrine nasal spray) 2 mg ...

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 millionPreliminary cash, cash equivalents and short-term investments ...

ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows ...

Other approvals are expected to "make treatment more convenient for consumers," like Neffy, the first nasal spray for severe allergic reactions, according to Murdock. "This is the first needle ...

Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...

neffyinSchools provides eligible public and private K-12 schools in the U.S. with the opportunity to receive two cartons (four single use doses) of neffy ® (epinephrine nasal spray) 2 mg for use ...

INDICATION AND IMPORTANT SAFETY INFORMATION FOR neffy (epinephrine nasal spray) INDICATIONneffy 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis ...

In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose of neffy in the same nostril with a new nasal spray starting 5 minutes after the ...

neffyinSchools provides eligible public and private K-12 schools in the U.S. with the opportunity to receive two cartons (four single use doses) of neffy® (epinephrine nasal spray) 2 mg for ...

unaudited neffy ® (epinephrine nasal spray) net product revenue for the fourth quarter and full year 2024 and outlined its 2025 commercial and clinical objectives. Cash position: Cash ...